These results, along with a preceding report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 guidance the strategy of targeting ACKR3 as a novel solution to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-associated Diseases. At that point, Microsoft Advertising https://thomash036fbx3.corpfinwiki.com/user